KPV (Lysine–Proline–Valine)
KPV (Lysine–Proline–Valine)5mg
Lemon Bottle
Lemon Bottle is a formulation commonly referenced in cosmetic and aesthetic research discussions for its association with localized fat-related studies. It is known for combining bioactive components that are examined for their interaction with adipose tissue and metabolic signaling at the cellular level.
Livagen 20mg (Bioregulator)
Livagen is a synthetic peptide bioregulator derived from liver tissue extracts composed of short amino acid sequences that influence hepatic gene expression and detoxification processes. It has been shown in experimental models to regulate protein synthesis, antioxidant activity, and lipid metabolism. Livagen is utilized in molecular and biochemical research exploring peptide-mediated hepatic homeostasis and gene regulation mechanisms.
Longevity, Performance & Obesity Research (60 Capsules)
5-amino-1MQ is a small molecule that blocks the activity of the enzyme called nicotinamide N-methyltransferase (NNMT). By blocking NNMT, 5-amino-1MQ stimulates an increase in NAD+, a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1). SIRT1 is also known as the "longevity gene" because of its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other forms of cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
Melanotan 2 (MT2) (3mg x 10 Vials = 30mg)
Melanotan-2 (MT-2) is a synthetic derivative of human alpha-melanocyte-stimulating hormone (α-MSH), developed at the University of Arizona in the 1980s. The initial purpose was to create a sunless tanning alternative, inspired by α-MSH's ability to induce sexual arousal and skin darkening in rodents. However, as research progressed, MT-2's diverse effects were unveiled. These include enhancing sexual arousal, promoting skin pigmentation, reducing compulsive behavior, managing addiction, suppressing hunger, decreasing glucagon production, and even potentially reversing certain features associated with autism. Melanotan-2 research has shown it to enhance sexual arousal, promote skin pigmentation through melanocyte activation and reduce compulsive/addictive behaviors.
Methylene Blue
Methylene Blue is a well-studied redox-active compound, meaning it can both donate and accept electrons — a key function in cellular energy processes. This allows it to enhance mitochondrial function by supporting the electron transport chain, improving ATP production and reducing oxidative stress. Research shows it also modulates inflammatory pathways and protects mitochondrial integrity. Methylene Blue is studied for its neuroprotective, metabolic, and anti-aging properties, making it a promising compound for brain health and cellular resilience.
MK-677 (Ibutamoren) 12.5mg (60 Capsules)
MK-677, is a orally bio-active, selective agonist of the ghrelin receptor. Research shows that MK-677 increases the natural secretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), but does not affect cortisol levels. It is being researched as a possible treatment for GH deficiency, muscle and bone wasting, appetite stimulation and Alzheimer's disease. MK-677 research in mice, appeared to prevent the onset of AD, even in genetically predisposed mice, as long as it was started before significant amyloid beta accumulation. MK-677 research has also shown exceptionally promising benefits in improving sleep quality.
Mod GRF, GHRP-2 10mg (Blend)
Mod GRF and GHRP-2 is a research peptide blend combining GHRH and ghrelin receptor agonists for experimental GH axis modeling. Mod GRF (CJC-1295 no DAC) engages GHRH receptor–driven cAMP/PKA signaling, while GHRP-2 binds GHS-R1a, activating Gq/11-mediated calcium release. This blend is applied in preclinical studies to analyze peptide synergy, pituitary signaling, and endocrine regulation mechanisms.
Mod GRF, GHRP-6 10mg (Blend)
Mod GRF and GHRP-2 is a research peptide blend combining GHRH and ghrelin receptor agonists for experimental GH axis modeling. Mod GRF (CJC-1295 no DAC) engages GHRH receptor–driven cAMP/PKA signaling, while GHRP-2 binds GHS-R1a, activating Gq/11-mediated calcium release. This blend is applied in preclinical studies to analyze peptide synergy, pituitary signaling, and endocrine regulation mechanisms.
Mod GRF, Hexarelin 10mg (Blend)
Mod GRF and GHRP-2 is a research peptide blend combining GHRH and ghrelin receptor agonists for experimental GH axis modeling. Mod GRF (CJC-1295 no DAC) engages GHRH receptor–driven cAMP/PKA signaling, while GHRP-2 binds GHS-R1a, activating Gq/11-mediated calcium release. This blend is applied in preclinical studies to analyze peptide synergy, pituitary signaling, and endocrine regulation mechanisms.
